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ARTICLE
A prometaphase mechanism of securin destruction
is essential for meiotic progression in mouse
oocytes
Christopher Thomas 1,3✉, Benjamin Wetherall 1, Mark D. Levasseur1, Rebecca J. Harris 1,
Scott T. Kerridge 1, Jonathan M. G. Higgins 1, Owen R. Davies 1,2 & Suzanne Madgwick 1✉
Successful cell division relies on the timely removal of key cell cycle proteins such as securin.
Securin inhibits separase, which cleaves the cohesin rings holding chromosomes together.
Securin must be depleted before anaphase to ensure chromosome segregation occurs with
anaphase. Here we find that in meiosis I, mouse oocytes contain an excess of securin over
separase. We reveal a mechanism that promotes excess securin destruction in prometaphase
I. Importantly, this mechanism relies on two phenylalanine residues within the separase-
interacting segment (SIS) of securin that are only exposed when securin is not bound to
separase. We suggest that these residues facilitate the removal of non-separase-bound
securin ahead of metaphase, as inhibiting this period of destruction by mutating both residues
causes the majority of oocytes to arrest in meiosis I. We further propose that cellular securin
levels exceed the amount an oocyte is capable of removing in metaphase alone, such that the
prometaphase destruction mechanism identified here is essential for correct meiotic pro-
gression in mouse oocytes.
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Successful cell division depends on the ordered degradationof key cell cycle proteins. In both mitosis and meiosis, thisdegradation relies on the activity of the anaphase-
promoting complex (APC/C)1. The APC/C recognises its sub-
strates through short linear motifs known as ‘degrons’2. Once
recruited, APC/C substrates are ubiquitinated and delivered to
the 26S proteasome for degradation. The ordering of APC/C
substrate recruitment is determined by the degrons present
within a substrate, as well as by the composition and post-
translational modification of APC/C subunits. A principal factor
determining which substrates are targeted at a given time is the
identity of the co-activator protein (Cdc20 or Cdh1) present at
the APC/C3.
Securin is an APC/C substrate in both mitosis and meiosis4,5.
Prior to its degradation, securin functions to inhibit the protease
separase which, when activated, cleaves the cohesin rings that
hold chromosomes together6–17. The inhibitory function of
securin is mediated through direct binding of its C-terminal
region or ‘SIS’ (separase-interacting segment) across the surface
of separase18–20. The SIS is known to contain a pseudosubstrate
motif that sits within the active site of separase. Indeed, when
residues within the pseudosubstrate motif in yeast securins are
switched to match equivalent residues in the separase substrate
Scc1, securin is efficiently cleaved9,21. In addition, securin con-
tains a conserved LPE (leucine-proline-glutamic acid) motif
upstream from the pseudosubstrate motif but also within the SIS.
An LPE motif is also found in Scc1 and was shown to enhance
cleavage by separase through a docking interaction away from the
active site. However, securin’s LPE motif blocks this interaction,
providing a second mechanism by which securin-separase bind-
ing directly inhibits cohesin cleavage22.
Alongside a critical role in driving chromosome alignment,
cyclin B1-Cdk1 activity has also been shown to inhibit separase.
This inhibition is mediated by Cdk1 phosphorylation of separase
and subsequent complex formation between cyclin B1 and
separase23–26. The binding of separase with either securin or
cyclin B1 is mutually exclusive, and the relative contribution of
each inhibitory pathway varies depending on cell type and
developmental state24,27. In fixed meiosis I (MI) mouse oocytes, it
has been reported that either securin or cyclin B1-Cdk1 mediated
separase inhibition may be perturbed independently without an
increase in premature chromosome separation28. Errors in seg-
regation were only detected when both inhibitory pathways were
removed. Interestingly, however, the situation is different in
meiosis II where securin depletion alone leads to complete
chromatid separation, suggesting a change in the way separase is
inhibited between the two meiotic cycles28,29. Importantly
though, while securin may be dispensable in some cells, it must be
removed ahead of anaphase to ensure the timely release of
separase activity4,30. Furthermore, the degradation of securin
must be coupled to the degradation of cyclin B130–32. This is to
ensure that separase activation and the poleward movement of
chromosomes, triggered by a loss of cyclin B1-Cdk1 activity, are
synchronous.
In mitosis, the synchronous loss of securin and cyclin B1 is
ensured by the similarity of their destruction mechanisms. Both
are ubiquitinated by the APC/C during metaphase4,33. Critically,
this degradation relies on both the availability of the APC/C co-
activator protein Cdc20 and on the D-box motif present within
the N-terminus of both securin and cyclin B134–36. Once all
chromosomes are properly attached to spindle microtubules in
metaphase, Cdc20 and the APC/C form a bipartite D-box
receptor37. Prior to this, Cdc20 is sequestered by the spindle
assembly checkpoint (SAC); a diffusible signal generated at each
unattached kinetochore. The SAC thus functions to block the
formation of the APC/C-Cdc20 bipartite D-box receptor,
preventing securin and cyclin B1 destruction until all chromo-
somes are attached to spindle microtubules38–40. In contrast,
where APC/C substrates must be targeted prior to metaphase
alignment, additional motifs are present that function to bypass
the SAC. One example of this is the ABBA motif in cyclin A,
which directly outcompetes SAC protein binding of Cdc2041,42.
Through this mechanism, the ABBA motif in cyclin A permits D-
box-dependent degradation in prometaphase during an active
SAC.
In contrast to mitosis, securin and cyclin B1 destruction initiate
during prometaphase in mouse oocyte meiosis I, prior to full
chromosome alignment43,44. At first, this might seem like a
failure to ensure accurate chromosome segregation. However, our
recent work demonstrates that cyclin B1 is present in excess of
Cdk1 in prometaphase I in mouse oocytes44. At this time,
destruction represents only the loss of non-Cdk1-bound cyclin
B1. Cdk1-bound cyclin B1 is preserved, prolonging the period
over which high Cdk1 activity is present in the oocyte. The
degradation of non-Cdk1-bound cyclin B1 in prometaphase I
thereby represents a key feature of a mechanism that functions to
prevent aneuploidy in mouse oocytes. Importantly, free cyclin B1
is targeted to the APC/C by a motif in addition to the D-box (the
PM motif), which is only accessible in the unbound pool of cyclin
B1. By this strategy, an excess of cyclin B1 acts as an APC/C
decoy to maintain Cdk1 activity and prolong prometaphase in
oocyte meiosis I. This is critical in mouse oocytes since, in the
absence of excess cyclin B1, SAC activity is not sufficient to
prevent anaphase for long enough to fully align chromosomes; a
process that takes hours in oocyte meiosis I rather than the tens of
minutes to complete mitosis44.
Given that securin and cyclin B1 degradation occur synchro-
nously during prometaphase I, our cyclin B1 findings raised sig-
nificant questions regarding securin degradation in oocyte meiosis.
We find that securin exists in excess of separase in oocyte
meiosis I. We suggest that the excess of securin present in MI
exceeds that which the oocyte is capable of removing efficiently in
metaphase alone. We identify key residues within the SIS of
securin that permit the removal of the non-separase-bound
securin fraction in late prometaphase I. Furthermore, we present
evidence that non-separase-bound securin is targeted for degra-
dation by a previously unidentified destruction mechanism that is
essential for correct meiotic progression. Where we inhibit pro-
metaphase destruction of the securin excess, exit from meiosis I is
either delayed or blocked completely.
Results
Securin destruction begins 2 hours ahead of separase activation
in meiosis I in mouse oocytes. In mitosis, securin is destroyed
alongside cyclin B1 and only in metaphase, once the spindle
checkpoint is inactivated in response to correct attachment of all
kinetochores to microtubules4,33. In contrast, while securin and
cyclin B1 are also targeted simultaneously in meiosis I in mouse
oocytes, their destruction initiates much earlier, ahead of full
chromosome alignment and spindle migration in prometaphase
(Fig. 1a). However, as division errors are rare in mouse oocytes, it
seemed unlikely that this early securin and cyclin B1 destruction
affects separase activity so far ahead of anaphase. To test this, we
used a separase activity biosensor generated by Nam et al. that has
previously been validated in HeLa cells, mouse embryonic fibro-
blasts (MEFs) and oocytes45–48. The sensor consists of a
nucleosome-targeted H2B protein fused to eGFP and mCherry
fluorophores. Between the two fluorophores, an Scc1 peptide
sequence is cleaved by active separase (Fig. 1b). Scc1 cleavage
results in a yellow to red colour shift as the eGFP signal dissociates
into the cytoplasm and mCherry remains bound to histones
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associated with chromosomal DNA. We injected germinal vesicle
(GV) stage oocytes with mRNA encoding this biosensor and
imaged cells through MI maturation. Here, we consistently
observed a clear shift in colour just 20–30minutes ahead of the
first polar body (PB1) extrusion (Fig. 1c). This timing was con-
firmed by the quantification of the mCherry/eGFP fluorescence
ratio (Fig. 1a). The data indicate that separase is only active from
30minutes ahead of PB1 extrusion, with the majority of substrate
cleavage taking place in the final 20 minutes. Importantly, this
demonstrates that separase becomes active >2 hours after the
initiation of securin destruction.
The D-box is insufficient for wild-type securin destruction in
MI. In mouse oocytes, cyclin B1 is destroyed by a two-step
mechanism; an initial period of prometaphase destruction
requires both a D-box and an additional motif termed the PM
motif. This is followed by a second period of destruction as the D-
box becomes sufficient once the SAC is satisfied in metaphase44.
Given that securin and cyclin B1 destruction is synchronous in
oocytes, we reasoned that securin may also be destroyed by a
similar mechanism43,44. We first confirmed previous findings that
securin destruction in oocyte meiosis I is APC/C-dependent using
ProTAME, a small molecule inhibitor shown to block APC/C
activation (Fig. 2a)5,49,50. Then to test whether, like cyclin B1,
securin destruction was biphasic, we designed and tested two
fluorescent reporters; full-length securin (securin FL) and the N-
terminal 101 residues (securin N101). Critically, both constructs
contain the D-box and KEN box4,30, lysine 4851 and TEK boxes52
reported to be necessary for securin recognition by the APC/C
a
b









-4 -3 -2 -1 0 








Separase activity sensor 
Time in minutes relative to PB1 extrusion
-30 -20 -10 0 10
eGFP























Fig. 1 Securin destruction begins 2 hours ahead of separase activation in mouse oocyte meiosis I. a Graph showing the mean destruction profiles of VFP-
tagged securin FL (magenta trace, n= 25) and cyclin B1 FL (blue trace, n= 62) alongside separase activity as determined by a separase activity biosensor
(mCherry/eGFP ratio, n= 21) in MI mouse oocytes relative to PB1 extrusion. Error bars ± SEM. Representative confocal images show a maturing oocyte
expressing Map4-GFP (microtubules in green) and incubated with SiR-DNA (DNA in red) at times relative to the x axis of the graph. Scale bar= 10 µm. b
Schematic diagram of an H2B-mCherry-Scc1-eGFP separase activity biosensor. c Representative time-lapse images of an oocyte expressing the separase
activity biosensor in Fig. 1b, imaged every 10 minutes at the times indicated relative to PB1 extrusion. eGFP (green), mCherry (red) and merged
fluorescence + bright-field (BF) images are shown. Scale bar= 10 µm. eGFP and mCherry images correspond to the areas marked by the white dotted lines
in the merge + BF images. Images displayed in a and c are representative of between 10 and 20 oocytes from experiments repeated at least three times.
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and subsequent proteolysis (Fig. 2b). These two securin reporters,
and all that follow, were coupled to Venus fluorescent protein
(VFP) to give a direct readout of exogenous protein level in the
oocyte.
Strikingly, we found that securin FL was consistently targeted
for destruction earlier than securin N101 (~80 minutes; Fig. 2c).
Furthermore, when we compared the data generated in our cyclin
B1 study, we found that securin N101 destruction was restricted
to metaphase, in time with a cyclin B1 N-terminus reporter
(cyclin B1 N90) that contains the D-box but lacks the PM motif.
This observation raised the possibility that, similar to cyclin B1
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is necessary to act alongside the D-box to direct wild-type securin
degradation in prometaphase I in oocytes.
A discrete region within the C-terminus of securin promotes
destruction in prometaphase. To test if a second destruction
motif exists within securin to facilitate prometaphase destruction,
we replaced a highly conserved region located between residues
109–133 (Fig. 2d; full securin alignment is shown in supple-
mentary fig. 1a) with a neutral 25 amino-acid TGSGP repeat
linker in the full-length securin construct (securin Δ109–133).
This construct was targeted for destruction in time with securin
N101 (Fig. 2e) ~80 minutes after securin FL, indicating that
residues between 109 and 133 are essential for a normal pattern of
securin destruction in oocyte meiosis I.
Following this, we divided residues 109–133 into three groups
based on sequence conservation, mutating each group to
determine its importance in timing securin degradation (Supple-
mentary fig. 1b). Based on sequence similarity with the PM motif
in cyclin B1 (which centers on residues 170DIY172 in the mouse
ortholog), we predicted that the first mutant (securin DAYPEIE-
A) would eliminate prometaphase targeting. Surprisingly, how-
ever, securin DAYPEIE-A was instead targeted in time with
securin FL (Supplementary fig. 1c). In contrast, both FFPFNP-A
and DFESFD-A mutations resulted in dramatic shifts in
destruction timing (Supplementary fig. 1d–e). Securin FFPFNP-
A was targeted for destruction ~60 mins after securin FL but still
~20 minutes ahead of securin N101 (Supplementary fig. 1d),
while securin DFESFD-A destruction mirrored that of securin
N101 (Supplementary fig. 1e). This suggests that residues
essential for wild-type prometaphase securin degradation lie
within both of these regions.
Since securin DFESFD-A showed the most striking phenotype,
we mutated a pair of highly conserved phenylalanines (F125 and
F128) to alanines (securin FF-A; Fig. 2f). Here, degradation was
delayed by 90 minutes, mimicking that of securin N101 (Fig. 2g;
see supplementary fig. 1f for destruction timings of all mutants).
Importantly, mutation of residues F125 and F128 to alanines did
not impair securin binding to separase as shown by immuno-
precipitation (Supplementary fig. 1g). We suggest that these two
phenylalanine residues are a crucial component of a previously
unidentified recognition mechanism that permits securin destruc-
tion in late prometaphase I in oocytes. In the absence of this
mechanism, securin destruction initiates 90 minutes later and
only in metaphase. Interestingly, these two residues and their
surrounding region have no sequence similarity with the PM
motif present in cyclin B1.
To confirm that the difference in degradation timing observed
between securin FL and securin FF-A was not simply due to
differences in protein expression, oocytes were treated with
cycloheximide (CHX) to block protein synthesis (Supplementary
fig. 1h). Following CHX addition, securin FL protein turnover
was evident—~20% of the total protein was lost before a steep
period of destruction began 4 hours later. In contrast, securin FF-
A levels were relatively stable until destruction began ~5.5 hours
after CHX addition. Critically, accelerated securin FF-A destruc-
tion begins ~90 minutes after securin FL, consistent with results
from non-CHX-treated oocytes.
Securin FL destruction in mouse oocytes begins in prometa-
phase I at a time when the SAC is active as indicated by detectable
Mad2 staining at kinetochores53. In contrast, securin FF-A
destruction initiates at a later time point, once chromosomes are
aligned at the metaphase plate and the spindle has migrated to the
cortex (Fig. 1a). This suggests that the SAC might have less
influence over securin FL than securin FF-A. To assess this, we
treated oocytes with 150 nM nocodazole. This dose of nocodazole
depolymerises microtubules and activates the SAC such that PB1
extrusion is blocked in >98% of oocytes. Under these conditions,
securin FL degradation still occurred but was significantly
reduced and delayed. In these oocytes, a gradual decline in
securin FL protein levels was observed but only from ~13 hours
after GVBD. In contrast, securin FF-A was largely stabilised over
the same time period (Fig. 2h). Thus, while the degradation of
both constructs is responsive to an increased SAC signal, securin
FL is more readily turned over during an active SAC. We,
therefore, questioned whether securin FL and securin FF-A would
be differentially targeted when SAC signalling was removed. To
assess this, we treated oocytes with 100 nM reversine to inhibit
Mps1 and block assembly of new SAC complexes. As expected,
reversine treatment rapidly accelerated progression through
meiosis I, with securin FL degradation beginning around 30
minutes after drug addition (Fig. 2i). In the absence of SAC
signalling, securin FL was still targeted for destruction signifi-
cantly ahead of securin FF-A. Noticeably in both control and
reversine treated oocytes, the bulk of securin FF-A degradation
takes place after securin FL protein levels have been depleted
(Fig. 2i).
Together our data suggest that a mechanism involving securin
residues F125 and F128 functions to permit securin degradation
during late prometaphase I. During this period, the D-box alone
is insufficient for substrate targeting and degradation. The D-box
is however still essential for both phases of securin destruction
(prometaphase and metaphase) since D-box ablation perturbs
Fig. 2 A discrete region within the C-terminus of securin promotes destruction in prometaphase. a Mean VFP-tagged securin FL (purple dashed trace,
n= 11) destruction profile following incubation in 1.5 µM ProTAME to inhibit APC/C activity. Mean VFP-tagged securin FL (magenta trace, n= 16)
destruction profile in control oocytes is included as a reference. ProTAME treated oocytes do not extrude a polar body and are therefore aligned at GVBD.
b Schematic showing VFP-tagged securin and cyclin B1 constructs. c Mean securin FL (magenta trace, n= 25), securin N101 (pink dashed trace, n= 23),
cyclin B1 FL (blue trace, n= 33) and cyclin B1 N90 (light blue dashed trace, n= 34) destruction profiles relative to PB1 extrusion. d Full sequence alignment
conservation annotation and multiple sequence alignment of residues 109–133 in securin orthologs. e Mean VFP-tagged securin FL (magenta trace, n=
25), securin N101 (pink dashed trace, n= 23) and securin Δ109–133 (light blue trace, n= 23) destruction profiles relative to PB1 extrusion. f Schematic
showing the position of Securin FF-A amino-acid substitutions. Residues F125 and F128 (shown in green in the wild-type protein) were switched to alanines
(shown in red in Securin FF-A). g Mean VFP-tagged securin FL (magenta trace, n= 25), securin N101 (pink dashed trace, n= 23) and securin FF-A (green
trace, n= 20) destruction traces relative to PB1 extrusion. h Mean VFP-tagged securin FL (magenta dashed trace, n= 23) and securin FF-A (dark green
dashed trace, n= 30) destruction profiles following incubation in 150 nM nocodazole to arrest oocytes in prometaphase. Mean VFP-tagged securin FL
(magenta trace, n= 16) and securin FF-A (green trace, n= 16) destruction profiles in control oocytes are included as a reference. Nocodazole treated
oocytes do not extrude a polar body and are therefore aligned at GVBD. iMean VFP-tagged securin FL (purple dashed trace, n= 16) and securin FF-A (dark
green dashed trace, n= 16) destruction profiles following incubation in 100 nM reversine to block assembly of new SAC complexes. Mean VFP-tagged
securin FL (magenta trace, n= 16) and securin FF-A (green trace, n= 16) destruction profiles in control oocytes are included as a reference. Reversine
treated oocytes have an accelerated progression through meiosis and are therefore aligned at GVBD. All n numbers refer to the number of individual
oocytes analysed over a minimum of three independent experiments. All error bars ± SEM.
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destruction throughout MI and inhibits PB1 extrusion (Supple-
mentary fig. 2b). Interestingly, when the D-box is mutated, a
small amount of destruction is still observed in traces from
individual oocytes. This destruction is likely mediated by the KEN
box in securin, as ablation of both KEN and D-box together
resulted in a more complete stabilisation (Supplementary fig. 2c).
In contrast, KEN box ablation alone did not affect securin
destruction (Supplementary fig. 2d).
Our data presented in Fig. 2 are consistent with a two-step
securin destruction process in MI oocytes. An initial period of
destruction from 3 hours ahead of PB1 extrusion requires both
the D-box and an additional region, with an absolute requirement
for residues F125 and F128. This is followed by the second period
of destruction in metaphase as the D-box becomes sufficient for
degradation 1 hour ahead of PB1 extrusion. Critically, our
separase biosensor data indicate that separase is only active
during the latter half of the second phase of securin destruction.
Two phenylalanine residues key to prometaphase securin
destruction are predicted to be masked when securin is bound
to separase. Interestingly, F125 and F128 are positioned within
securin’s separase interaction segment (SIS), in the vicinity of
both the pseudosubstrate motif and the LPE-docking
motif18,20,22. We therefore asked how these phenylalanine resi-
dues are positioned when securin is in complex with separase.
Since a mammalian crystal structure for the securin-separase
complex is yet to be solved, we instead used the structure of the S.
cerevisiae complex as a reference18. Critically, these residues and
the surrounding region are largely conserved between mammals
and yeast (Fig. 3a). In this structure, residues Y276 and F279,
corresponding to F125 and F128 in the human protein, sit deep
within a hydrophobic binding pocket on the surface of separase
(Fig. 3b). It is therefore highly likely that these two residues are
obscured when securin is in complex with separase. The con-
servation of these residues throughout eukaryotes (Fig. 3a),
coupled with their positioning near the pseudosubstrate region of
securin, leads us to propose that both phenylalanine residues
would be similarly hidden in other species.
Securin is present in excess over separase in mouse oocytes.
Given that F125 and F128 are predicted to be concealed when
securin is bound to separase, we hypothesised that securin
destruction in prometaphase must represent that of a non-
separase-bound population.
In mitosis, securin protein is in excess of separase31,46,54. This
ratio has been quantified in HeLa cells by immunoprecipitation
experiments, where free securin is reported to be 4–5-fold more
abundant than separase-associated securin54. We, therefore,
considered that a similar excess of securin in oocytes could
provide the basis for a two-step pattern of securin degradation.
Given that immunoprecipitation experiments are not practical
using mammalian oocyte lysates, we employed an alternative
strategy to probe the securin to separase ratio. We designed and
generated a construct where separase and securin are physically
linked, and injected oocytes with mRNA encoding this construct
(Fig. 3c). We reasoned that the resultant exogenous protein would
act as a control in western blotting experiments, presenting as a
larger protein than either endogenous securin or separase
individually and always at a 1:1 ratio. Following extensive
analysis, we propose that securin is 3–4-fold more abundant than
separase in mid-prometaphase in MI mouse oocytes (Supple-
mentary fig. 3).
In the second series of experiments using the same linked
construct (separase-securin FL), we investigated how separase-
binding affects the timing of securin degradation in oocytes. We
reasoned that the design of the separase-securin FL construct
would greatly enhance securin-separase binding relative to that
between the securin-only construct (securin FL) and endogenous
separase. This situation should delay the destruction of the linked
securin relative to FL securin. Indeed, where we recorded the
degradation profiles of separase-securin FL alongside securin FL,
loss of the linked protein complex initiates ~70–80 minutes later,
consistent with the timing of securin FF-A degradation (Fig. 3d).
Our data so far suggest a mechanism by which a pool of excess
non-separase-bound securin is preferentially targeted for destruc-
tion in late prometaphase. This mechanism involves both the D-
box and a second region within the SIS of securin where F125 and
F128 are essential. Following this, a smaller pool of separase-
bound securin becomes a destruction target in metaphase.
Preferential destruction of non-separase-bound securin has
previously been demonstrated in HeLa cells. Hellmuth et al.54
showed that separase-bound securin is dephosphorylated by
PP2A-B56 phosphatase, whereas free securin exists in a
phosphorylated state and is a preferential APC/C target.
Importantly, however, the mitotic destruction of both separase-
bound and non-separase-bound securin takes place in metaphase,
only after SAC satisfaction. It, therefore, seems unlikely that this
same mechanism is responsible for the degradation of non-
separase-bound securin in prometaphase in mouse oocytes. To
assess this, we generated phospho-null and phosphomimetic
securin FL and securin FF-A by mutating the four key
phosphorylation sites in securin identified by Hellmuth et al.
(S31, T66, S87 and S89) to either alanine (4A; phospho-null), or
glutamic acid (4E; phosphomimetic). mRNA was injected
encoding these constructs and destruction profiles were recorded
(Supplementary fig. 4). Surprisingly, for both securin FL and
securin FF-A proteins, the phosphomimetic mutation showed a
delayed degradation, the opposite of its effect in mitosis. In
contrast, the phospho-null mutation brought securin FF-A
degradation slightly earlier but had no effect on securin FL
(Supplementary fig. 4).
We therefore suggest that while phosphorylation may fine-tune
the degradation timing of both constructs, the mechanism of
non-separase-bound securin degradation described in this manu-
script does not absolutely depend on phosphorylation status. The
preferential degradation of non-separase-bound securin is more
likely mediated by a steric interaction with the APC/C or its co-
activator.
F125 and F128 are essential for the efficient removal of securin
in oocyte meiosis I—where this mechanism is perturbed,
oocytes fail to divide. Although the presence of securin is not
essential in MI oocytes, its removal at the end of meiosis I is an
absolute prerequisite for cell division30. We therefore wondered if
F125 and F128 function to efficiently remove the non-separase-
bound excess of securin ahead of anaphase, mitigating the
potential to overwhelm the APC/C in metaphase. Where cyclin
B1 is concerned, the majority of oocytes are not capable of
removing an excess of cyclin B1 in metaphase if prometaphase
destruction is prevented. These oocytes instead arrest in meta-
phase or early anaphase44.
To test whether the same applies for securin, we knocked down
securin protein levels with a morpholino oligo (MO) such that in
prometaphase, MO oocytes contained ~13% of the protein level
relative to control oocytes (quantified by western blot; Fig. 4a).
Despite severe depletion of securin, cell cycle timings and PB1
extrusion rates were normal (Fig. 4b, c). This result agrees with
observations made in fixed oocytes, suggesting that cyclin B1-
Cdk1 levels are sufficient to compensate for the loss of securin in
meiosis I28. We then added back an equivalent amount (as
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24554-2
6 NATURE COMMUNICATIONS |         (2021) 12:4322 | https://doi.org/10.1038/s41467-021-24554-2 | www.nature.com/naturecommunications
quantified by western blot in Supplementary fig. 3a) of either
securin FL or securin FF-A to investigate how oocytes progress if
the prometaphase destruction mechanism is perturbed. Adding
back securin FL showed a destruction profile and PB1 extrusion
rate comparable to control oocytes (Fig. 4b, c). In contrast, when
securin protein levels were rescued with securin FF-A, destruction
was impaired and PB1 extrusion was either delayed by hours or
blocked completely. Indeed, only 26% of these oocytes completed
meiosis I and extruded a polar body. Whether these oocytes
blocked in meiosis I or progressed into meiosis II with a delay
in PB1 extrusion was partially dependent on securin FF-A protein
levels. In general, those that blocked had higher levels of securin
FF-A prior to the onset of destruction. However, as mRNA
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Fig. 3 F125 and F128 are predicted to direct the prometaphase destruction of a pool of non-separase-bound excess securin. a Multiple sequence
alignment of the region surrounding residues F125 and F128 (marked with asterisks) in securin orthologs. b The molecular surface of separase (green) in
contact with the region of securin detailed in Fig. 3a (purple). Image generated using the crystal structure of the Saccharomyces cerevisiae separase-securin
complex (PDB accession 5U1T [10.2210/pdb5U1T/pdb])18. The side chains of securin residues Y276 and F279, which correspond to F125 and F128 in the
human protein, are shown as stick models and labelled in purple. The N- and C-termini of the securin segment displayed are also labelled in purple c
Schematic representation of a tethered separase-securin complex reporter (separase-securin FL) including a cartoon demonstrating predicted complex
interaction. dMean VFP-tagged securin FL (magenta trace, n= 8) and separase-securin FL (green trace, n= 6) destruction profiles relative to PB1 extrusion.
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controlled for, we suggest that the higher protein levels seen in
some FF-A injected oocytes may suggest a role for F125 and F128
in securin turnover and housekeeping, though this remains a
focus of future investigation.
These observations are consistent with a mechanism that
allows for the efficient removal of excess securin during
prometaphase I in oocytes (Fig. 4d). When this mechanism is
perturbed and securin can only be targeted in metaphase, oocytes
frequently fail to divide.
Discussion
Progression through oocyte meiosis is driven by the timely
removal of key cell cycle proteins mediated by the APC/C. The
segregation of homologous chromosomes in anaphase I requires
that both securin and cyclin B1 have been sufficiently
depleted30,55. Importantly, the degradation of both proteins must
be temporally coupled. This ensures that Cdk1 inactivation,
triggering meiotic exit, is accompanied by separase activation30,44.
Active separase then cleaves the cohesin rings distal to cen-
tromeres that hold homologous chromosome pairs together
during meiosis I56. If securin is not degraded in time, the oocyte
arrests in metaphase I and cell division fails30. Here, we reveal the
existence of a novel mechanism of degradation that functions to
ensure the removal of excess securin ahead of metaphase.
We demonstrate that in meiosis I, mouse oocytes contain an
excess of securin over separase. Furthermore, we show that the
oocyte’s destruction machinery is not capable of removing this











6 8 12 10 14 16 







Securin MO + securin FL 
Securin MO + securin FF-A with PB 



































































Fig. 4 F125 and F128 are essential for the efficient removal of securin in oocyte meiosis I—where this mechanism is perturbed, oocytes fail to divide. a
Quantification of securin morpholino knockdown. Western blot of control and securin morpholino (MO) injected oocytes collected 5.5 hours post GVBD
(numbers of oocytes loaded per lane are indicated). Quantification of protein bands indicates an 87% knockdown of securin in MO-injected oocytes. The
lower blot was probed for vinculin and used as a loading control. b Securin protein levels were knocked down by morpholino (MO) injection. Oocytes were
subsequently injected with either securin FL (green traces, n= 6) or securin FF-A (yellow and red traces, n= 15). Although securin FL-injected oocytes had
normal rates and timings of PB1 extrusion, FF-A-injected oocytes were either delayed (yellow traces) or blocked in MI (red traces). Destruction profiles are
relative to GVBD. c Quantification of PB1 extrusion rate between control oocytes (purple column, n= 50), securin MO-injected oocytes (blue column, n=
29), and securin MO-injected oocytes subsequently injected with either securin FL (green column, n= 15) or securin FF-A (orange column, n= 23). All n
numbers refer to the number of individual oocytes analysed over a minimum of three independent experiments. Data presented as mean values with error
bars ± SEM. d A model summarising the mechanism by which a pool of excess non-separase-bound securin is preferentially targeted for destruction in late
prometaphase I in oocytes. This mechanism involves both the D-box and a second region within the SIS of securin where F125 and F128 are essential.
Following this, a smaller pool of separase-bound securin becomes a destruction target in metaphase.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24554-2
8 NATURE COMMUNICATIONS |         (2021) 12:4322 | https://doi.org/10.1038/s41467-021-24554-2 | www.nature.com/naturecommunications
of securin degradation that takes place in late prometaphase. In
addition to the D-box, two phenylalanine residues (F125 and
F128) within the C-terminus of securin are essential for this
prometaphase period of degradation. These residues are posi-
tioned within the SIS of securin18,20 and are predicted to be
masked when securin is bound to separase. Indeed, when we use a
reporter in which securin is directly tethered to separase, degra-
dation is delayed until metaphase. We therefore suggest that,
during late prometaphase, the APC/C primarily targets the non-
separase-bound pool of excess securin. Once the oocyte reaches
metaphase I, the D-box of securin becomes sufficient for degra-
dation, and a second destruction phase resembling mitotic
securin destruction proceeds. Interestingly, while in most eukar-
yotes the residues corresponding to F125 and F128 in human
securin are just downstream of the pseudosubstrate motif (Sup-
plementary fig. 1a), the recently solved Caenorhabditis elegans
securin-separase structure revealed the corresponding region to
be further upstream in the securin sequence and outside the SIS19.
This suggests that in C. elegans, these residues could be involved
in securin recruitment to APC/C-Cdc20 regardless of securin-
binding state. That this region in C. elegans retains high sequence
similarity to the equivalent region in the SIS of human securin,
despite different positioning within the protein, could hint at the
importance of these residues for their alternative function in the
regulation of degradation.
We propose that, in oocytes, the majority of non-separase-
bound securin is removed in prometaphase, while a smaller pool
of separase-bound securin is only targeted in metaphase. By this
strategy, the cellular destruction machinery is less likely to
become overwhelmed by an excess of substrate during the final
stages of chromosome segregation. When we inhibit prometa-
phase securin destruction by replacing excess endogenous securin
with a mutant lacking F125 and F128, the majority of oocytes fail
to complete meiosis I.
The mechanism by which free securin is recruited to the APC/
C in prometaphase is unclear. Notably, though, initiation of
securin destruction in late prometaphase I coincides with the
transition from Cdh1- to Cdc20-mediated APC/C activation55,57.
It has previously been observed that APC/C-Cdh1 activity med-
iates securin turnover in early prometaphase I57. However, it is
only after Cdc20 becomes the primary APC/C co-activator at ~6
hours post GVBD that a significant loss of securin protein is
observed30,43. It is therefore tempting to speculate that the cue for
prometaphase destruction of securin and cyclin B1 may be a
switch in APC/C co-activator, perhaps mediated by a change in
the phosphorylation status of the APC/C. Indeed, two recent
studies in mouse oocytes demonstrated that both securin and
cyclin B1 are stabilised in oocytes lacking cyclin B3; a B-type
cyclin that is highly expressed and essential in the germline but
dispensable in mitotic divisions48,58. In Drosophila, cyclin B3-
Cdk1 has been shown to phosphorylate APC3, promoting asso-
ciation between Cdc20 and the APC/C59.
Exactly how F125 and F128 in securin interact with the APC/C
during prometaphase I is unclear. Interestingly, this region in
securin does not share sequence similarity with the PM motif in
cyclin B144. Therefore, though their destruction timings are
coupled, it seems likely that the mechanisms by which they are
targeted are distinct. Indeed, when we inhibit SAC activity in
oocytes, while two phases of cyclin B1 destruction are no longer
apparent, securin FL is still destroyed in preference to securin
lacking these key phenylalanines. These data suggest that, while
the two phases of securin destruction have different sensitivities
to the SAC, the presence or absence of SAC activity is not the
only factor timing these destructions. We suggest that similar to
other prometaphase APC/C substrates, F125 and F128 could be
involved in direct interaction with APC/C-Cdc20. Notably, cyclin
A2 destruction in oocytes initiates in early prometaphase I
(Supplementary fig. 5a)48,60. This is likely mediated by a com-
bination of its ABBA, D-box, and KEN box motifs as well as
direct targeting to the APC/C through its Cdk-associated cofactor
Cks41,42,61. Interestingly, cyclin A1, which lacks an N-terminal
KEN box, is instead targeted 5 hours post GVBD, consistent with
Cdh1 being the primary APC/C co-activator in early prometa-
phase I60. It is worth noting that the region of securin containing
F125 and F128 bears similarity to the ABBA motif in cyclin A,
suggesting that this region of securin may interact with Cdc20
through the same interaction mode as observed in the crystal
structure of Acm1(ABBA)-Cdh162 (Supplementary Fig. 5b–e).
However, given that immunoprecipitation experiments are not
practical using mammalian oocyte lysates, we have been unable to
test this so far.
Our study is not the first to report a differential handling of
separase-bound and free securin by the APC/C. Hellmuth et al.54
previously reported that in HeLa cells, separase-bound securin is
dephosphorylated by PP2A and thus stabilised. Free securin on
the other hand was found to be in a phosphorylated state,
enhancing its ubiquitination by the APC/C. Importantly though,
degradation of both separase-bound and free securin in Hela cells
takes place in metaphase. In contrast to these findings in mitosis,
our data suggest that, in mouse oocytes, phosphorylation could
slightly delay the degradation of both free and separase-bound
pools of securin. Therefore, while this delay does not account for
the major temporal difference between free and separase-bound
securin destruction, phosphorylation may still fine-tune the
degradation timing of securin in oocytes.
While the removal of an excess of securin is clearly essential for
meiotic progression, it is not clear why such excess is present to
begin with. When securin protein levels are knocked down in
mouse oocytes, meiosis I proceeds with normal timing and
without segregation errors28,29. This is due to the existence of
compensatory mechanisms of separase inhibition in meiosis I.
Both securin- and cyclin B1-Cdk1-mediated separase inhibition
must be perturbed simultaneously in order to see an increase in
segregation defects28. In contrast, securin plays an important role
both before and after meiosis I in mouse oocytes. In prophase I,
securin functions to buffer APC/C-Cdh1-mediated destruction of
cyclin B1 during prophase arrest63. While in meiosis II, cyclin B1-
Cdk1 is no longer able to compensate for depleted securin and
severe segregation defects are observed28,29. It is therefore plau-
sible that an excess of securin in meiosis I could ensure a
threshold level throughout female meiosis in order to support
these roles. It should be noted however that neither role is
absolutely essential since female securin knockout mice are not
sterile, suggesting that in these mice alternative pathways may
operate in their place64.
An excess of securin may also be beneficial in oocytes from
aged mice where cohesin levels are significantly reduced65–70.
Compounding problems of cohesin loss, oocytes from aged mice
destroy securin more rapidly and to a greater extent than oocytes
from young mice71. As a consequence, separase inhibition is
incomplete in these cells, sister chromatid cohesion is lost pre-
maturely, and segregation defects are more frequent. Human
oocytes may additionally benefit from an excess of securin in
meiosis I, given that separase must be inhibited over a prome-
taphase period that lasts 14–18 hours, compared with 4.5–6.5
hours in mouse72–74.
We conclude that an excess of non-separase-bound securin is
present in mouse oocytes and must be removed in prometaphase
I. If prometaphase destruction is inhibited, the APC/C is likely
overwhelmed by the abundance of the substrate in metaphase,
resulting in a stalled meiosis. This period of destruction in pro-
metaphase necessitates a novel mechanism whereby non-
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separase-bound securin is preferentially targeted by the APC/C.
This targeting involves two conserved phenylalanine residues
which are likely masked in separase-bound securin. By this
strategy, separase-bound securin is preserved, likely allowing for a
switch-like activation of separase, essential for the fidelity of
anaphase.
Methods
Contact for reagent and resource sharing. Further information and requests for
resources and reagents should be directed to Suzanne Madgwick (suzanne.madg-
wick@newcastle.ac.uk).
Gamete collection and culture. Four-to-10-week-old female, outbred, CD1 mice
(Charles River) were used. All animals were handled in accordance with ethics
approved by the UK Home Office Animals Scientific Procedures Act 1986. How-
ever, given that mice did not undergo a ‘procedure’ as defined by the Act, the
project did not require Home Office Licensing. The reason for animal use was
instead approved and governed by Newcastle University’s Comparative Biology
Centre Ethics Committee; Study Plan Reference Number 699; AWERB Approval
Reference Number; 663. GV stage oocytes were collected from ovaries punctured
with a sterile needle and stripped of their cumulus cells mechanically using a
pipette. For bench handling, microinjections and imaging experiments, oocytes
were cultured at 37°C in medium M2 (Sigma) supplemented where necessary with
the addition of 30 nM 3-isobutyl-1-methylxanthine (Sigma) to arrest oocytes at
prophase I. Data were only collected from oocytes that underwent GVBD with
normal timings and had a diameter within 95–105% of the population average.
Where destruction profiles are displayed, n is the number of oocytes from which
the data have been gathered. To ensure reproducibility, oocyte data sets were
gathered from a minimum of three independent experiments. For each indepen-
dent experiment, both control and treatments groups were derived from the same
pool of oocytes, collected from a minimum of two animals. Oocytes were selected
at random for microinjection. Where necessary, and at the times indicated,
nocodazole (Sigma) was added to the media at a final concentration of 150 nM,
Mps1 inhibitor reversine (Sigma) at 100 nM75, the APC/C inhibitor ProTAME
(Boston Biochem) at 1.5 µM, and cycloheximide (Sigma) at 10 μg/ml76. For con-
focal imaging, SiR Hoechst was added to media 30 minutes prior to imaging at a
final concentration of 250 nM77.
Preparation of cRNA constructs for microinjection. Wild-type human securin,
separase, cyclin B1, Map4, and the separase biosensor (a gift from Jan Van
Deursen) were amplified by PCR. Mutations within securin and cyclin B1 were
generated by primer overhang extension PCR. A complete list of primers used,
including names and sequences, can be found in Supplementary Data 1. Following
this, we performed Sequence and Ligation Independent Cloning78 using modified
pRN3 vectors to generate either a construct with no further tags (the separase
biosensor) or constructs coupled to a VFP (all other sequences)79. Resultant
plasmids were linearised and cRNA for microinjection was prepared using a T3
mMESSAGE mMACHINE kit according to the manufactures instructions
(Ambion Inc.). Maximal stability was conferred on all cRNA constructs by the
presence of a 5′-globin UTR upstream and both 3’UTR and poly (A)–encoding
tracts downstream of the gene. cRNA was dissolved in nuclease-free water to the
required micropipette concentration. The cyclin B1 FL construct shown in Fig. 2c
contains a Y170A mutation which prevents Cdk1 binding44. This reporter is tar-
geted for destruction in time with wild-type cyclin B1 FL but crucially does not
affect endogenous Cdk1 activity.
Knockdown of gene expression using morpholinos. A Morpholino antisense
oligo designed to recognise the 5′-UTR of securin (sequence: GATAA-
GAGTAGCCATTCTGGATTAC; MO; Gene Tools) was used to knock down gene
expression. As per the manufacturer’s instructions, the oligo was stored at room
temperature, heated for 5 minutes at 65°C prior to use, and loaded at a micro-
pipette concentration of 1 mM.
Microinjection and imaging. Oocyte microinjection of the MO and construct
mRNAs was carried out on the heated stage of an inverted microscope fitted for
epifluorescence (Olympus; IX71). In brief, fabricated micropipettes were inserted
into cells using the negative capacitance overcompensation facility on an electro-
physiological amplifier (World Precision Instruments). This procedure ensures a
high rate of survival (>95%). The final volume of injection was estimated by the
diameter of displaced ooplasm and was typically between 0.1 and 0.3% of total
volume. Reporter construct protein levels were in the range of 25% of endogenous
protein levels, as quantified by western blot (Supplementary fig. 3a).
To generate destruction profiles, bright-field and fluorescence images were
captured every 10 minutes throughout meiosis I by an inverted Olympus IX71
microscope (fitted for epifluorescence) and CCD camera (Micromax, Sony
Interline chip, Princeton Instruments). Regions of interest were manually defined
around oocytes and fluorescence levels were measured in 2D. Further analysis was
carried out using MetaFluor software (version 7.7.0.0; Molecular Devices). All
experiments were performed at 37°C.
Confocal images (including all experiments using the separase biosensor) were
captured using a Zeiss LSM-800. Oocytes were imaged at 10 minute intervals
through 20+ Z-sections over a 12-hour period from GV stage. All experiments
were performed in a temperature-controlled, humidified chamber set at 37°C.
Bright-field and fluorescent images were recorded in Zen Blue (Zeiss) and
processed in Fiji. By this method, all oocytes extruded polar bodies.
Molecular structure images and multiple sequence alignments. Molecular
structure images were generated using the PyMOL Molecular Graphics System,
version 1.3 Schrödinger, LLC. Sequence conservation alignments were made by
importing protein sequences from Uniprot and aligning in Jalview, version 15.0.
The full sequence alignment conservation annotation shown in Fig. 2d is between
securin orthologs from Homo sapiens, Mus musculus, Sus scrofa, Bos Taurus,
T. alba, Xenopus laevis and Salmo salar. Alignment conservation annotation is a
quantitative index reflecting the conservation of the physico-chemical properties
for each column of the alignment. The tallest yellow columns represent sequence
alignment positions with the highest conservation. Shorter columns with increas-
ingly darker shades of brown represent sequence positions with decreasing con-
servation. All figures were prepared in Adobe Illustrator CC, version 17.1.0.
Mitotic cell cultures. Standard laboratory HeLa cells were used for immunopre-
cipitation experiments and cultured in flasks at 37°C, 5% CO2 in Dulbecco’s
Modified Eagle Medium (DMEM) (Lonza) with 10% fetal bovine serum (FBS, Life
Technologies) and antibiotics. Once cell coverage reached ~90%, flasks were treated
with 100 nM nocodazole for a 16-hour incubation period. Metaphase cells were
then collected by mechanical shake-off and lysed. MEFs were used as western
blotting standards and were a gift from Neil Perkins. MEFs were isolated as follows;
internal torso connective tissue from 13.5-day embryos was washed in sterile PBS
and minced in 1× Trypsin (Invitrogen) for 15 min at 37°C. Following repeated
pipetting to break up large tissue fragments, the cell pellet was resuspended in
DMEM (Lonza) supplemented with 20% FBS (Gibco, Paisley, UK) and 50 U/ml
penicillin/streptomycin (Lonza), and incubated at 37°C in a 5% CO2 humidified
atmosphere. Once cells reached 90% confluency, they were sub-cultured in 75cm2
flasks and considered as passage 1. Cells were then cultured following the standard
3T3 protocol80. Cells were considered immortalised beyond passage 14, but not
used in experiments beyond passage 25. Metaphase cells were then collected by
mechanical shake-off following an 8-hour incubation period in 100 nM
nocodazole.
Immunoprecipitation. HeLa cells transfected with securin FL, securin FF-A or
empty mVenus N1 transfection vector were synchronised and collected as
described above. Cells were then lysed in 50 mM Tris-HCl, pH 7.8, 150 mM NaCl,
0.5% NP-40 plus protease inhibitor cocktail (Roche) for 30 min on ice and clarified
by a 12,000 × g spin for 20 min at 4°C. Complexes were immunoprecipitated for 90
minutes at 4°C with GFP-Trap beads (Chromotek). After five washes in lysis buffer,
proteins were eluted from beads by incubating for 10 minutes at 95 °C in sample
buffer. The supernatant was then analysed by immunoblotting.
Immunoblotting. Mitotic MEF cell lysates were prepared using Laemmli buffer
following mechanical shake-off of metaphase cells. Oocytes were collected 5.5
hours after GVBD ± 15min and lysed in Laemmli buffer. Sodium dodecyl
sulphate–polyacrylamide gel electrophoresis and immunoblotting were carried out
by standard procedures. Immunoblot membrane sections were incubated for 16
hours at 4°C with either anti-securin (Abcam, AB3305; 1:5000), anti-separase
(Abnova, 6H6; 1:5000), or anti-vinculin (Cell Signaling, E1E9V; 1:2000). Non-fat
milk (5%) was used as a blocking solution and anti-mouse IgG (7076P2; Cell
Signaling; 1:20000 with AB3305 and 1:50000 with 6H6) and ECL Select (RPN2235;
GE Healthcare) were used as secondary detection reagents. ECL Select detection
reagents were specifically used to produce quantifiable chemiluminescent signals
with a broad linear dynamic range. Membranes were exposed to Hyperfilm x-ray
film (Amersham Biosciences) and developed using a SRX101 film processor
(Konica). Exposure time depended on the strength of the signal. Immunoblots are
representative of at least three independent blots. Uncropped versions of all blots
shown in figures can be found in the source data file.
Quantification and statistical analysis. Real-time destruction profiles were
recorded in MetaFluor (Molecular Devices) and data were automatically logged in
Excel. By taking an average VFP intensity reading from a defined region of interest
around the oocyte, fluorescence intensity was plotted over time and oocyte data sets
were aligned at PB1 extrusion unless otherwise stated. Average polar body extru-
sion timings were identical between experimental groups unless otherwise stated.
Fluorescence data values are arbitrary. In order to give the destruction profile of
each oocyte equal weighting, when generating a mean treatment destruction pro-
file, all individual data sets were normalised prior to calculation (taking the
maximum point of fluorescence prior to protein destruction as 100 arbitrary units).
However, like the examples shown in Figure S1i, we also compared all raw traces,
confirming that in each case experiment, the order and pattern of construct
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destruction remained the same, regardless of the data handling method. All
comparisons only include data from oocytes expressing constructs to similar levels
(see supplementary fig. S1i for example). Given the 1:1 ratio of the securin to VFP
component of each construct, we reasoned that comparable fluorescence levels
equate to comparable molar amounts. Oocytes with either excessive starting
amounts of reporter proteins, or with excessive translation rates were discounted.
All mean destruction traces have associated data sets in individual oocytes.
Mean cleavage profiles for separase biosensor experiments were produced in Fiji
by creating a clipping mask to the DNA using the far red signal emitted by SiR-
DNA treatment. The eGFP and mCherry intensity readings from the clipping mask
were then plotted over time and aligned at PB1 extrusion. eGFP/mCherry ratios
were calculated in Excel.
When only two constructs are compared, we have displayed both the mean
trace and individual traces. Where three or more constructs are compared, for
clarity, only the mean trace is shown with SEM error bars.
Structural modelling of the securinFF-Cdc20 complex. The crystal structure of
human Cdc20 (PDB accession 4GGC [https://doi.org/10.2210/pdb4GGC/
pdb]81) was superposed onto yeast Cdh1 of the Acm1-Cdh1 crystal structure
(PDB accession 4BH6 [https://doi.org/10.2210/pdb4BH6/pdb]62) with an rms
deviation of 0.60, using Phenix superpose82. The human securin sequence cor-
responding to amino acids 124–142 was threaded onto the Acm1 chain, map-
ping to amino acids 60–79, with one amino-acid gap between residues 65 and 67
(as indicated in supplementary fig. 5), using Coot83. Protein-peptide docking,
with optimisation of the peptide backbone and rigid body orientation, was
performed using the Rosetta FlexPepDock web server84,85. Models were ranked
according to their Rosetta full-atom energy score; the top ten models showed
scores of between −593.039 and −590.110, with rms deviations from the initial
model of between 1.911 and 3.122. The top ten models were superposed and
displayed together, and the top-ranked model was displayed superposed with the
Acm1-Cdh1 crystal structure (PDB accession 4BH6 [https://doi.org/10.2210/
pdb4BH6/pdb]62), using the PyMOL Molecular Graphics System, Version 2.0
Schrödinger, LLC.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this published article
(and its supplementary information files). Source data are provided with this paper.
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